GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Stock Based Compensation

AP Biosciences (ROCO:6945) Stock Based Compensation : NT$55.69 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is AP Biosciences Stock Based Compensation?

AP Biosciences's Stock Based Compensation for the six months ended in Dec. 2024 was NT$30.69 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 was NT$55.69 Mil.


AP Biosciences Stock Based Compensation Historical Data

The historical data trend for AP Biosciences's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AP Biosciences Stock Based Compensation Chart

AP Biosciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Stock Based Compensation
0.01 2.94 29.00 24.74 55.69

AP Biosciences Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Stock Based Compensation Get a 7-Day Free Trial 12.65 12.34 12.40 25.00 30.69

AP Biosciences Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$55.69 Mil.


AP Biosciences Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of AP Biosciences's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


AP Biosciences Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 17th Floor, Taipei, TWN
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.

AP Biosciences Headlines

No Headlines